GR900300046T1 - Oxabicycloheptane derivatives, pharmaceutical composition and use - Google Patents

Oxabicycloheptane derivatives, pharmaceutical composition and use

Info

Publication number
GR900300046T1
GR900300046T1 GR90300046T GR900300046T GR900300046T1 GR 900300046 T1 GR900300046 T1 GR 900300046T1 GR 90300046 T GR90300046 T GR 90300046T GR 900300046 T GR900300046 T GR 900300046T GR 900300046 T1 GR900300046 T1 GR 900300046T1
Authority
GR
Greece
Prior art keywords
group
sup
defined above
pharmaceutically acceptable
same
Prior art date
Application number
GR90300046T
Other languages
English (en)
Inventor
Toshio Tatsuoka
Kenji Suzuki
Kayoko Imao
Fumio Satoh
Seiji Miyano
Kunihiro Sumoto
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of GR900300046T1 publication Critical patent/GR900300046T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR90300046T 1986-02-27 1991-07-31 Oxabicycloheptane derivatives, pharmaceutical composition and use GR900300046T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61042732A JPH0723367B2 (ja) 1986-02-27 1986-02-27 オキサビシクロヘプタン誘導体

Publications (1)

Publication Number Publication Date
GR900300046T1 true GR900300046T1 (en) 1991-07-31

Family

ID=12644212

Family Applications (2)

Application Number Title Priority Date Filing Date
GR90400555T GR3000693T3 (en) 1986-02-27 1990-08-03 Oxabicycloheptane derivatives, pharmaceutical composition and use
GR90300046T GR900300046T1 (en) 1986-02-27 1991-07-31 Oxabicycloheptane derivatives, pharmaceutical composition and use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR90400555T GR3000693T3 (en) 1986-02-27 1990-08-03 Oxabicycloheptane derivatives, pharmaceutical composition and use

Country Status (8)

Country Link
US (1) US4713453A (el)
EP (1) EP0238883B1 (el)
JP (1) JPH0723367B2 (el)
AT (1) ATE52506T1 (el)
CA (1) CA1300138C (el)
DE (1) DE3762621D1 (el)
ES (1) ES2036183T3 (el)
GR (2) GR3000693T3 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3054207B2 (ja) * 1990-06-06 2000-06-19 サントリー株式会社 シクロプロパクロメン誘導体
JP3089040B2 (ja) * 1990-06-06 2000-09-18 サントリー株式会社 脳神経変性性疾患治療剤
US5401850A (en) * 1990-06-06 1995-03-28 Suntory Limited Cyclopropachromen derivatives
JP3993651B2 (ja) * 1994-10-21 2007-10-17 アスビオファーマ株式会社 シクロプロパクロメンカルボン酸誘導体
BRPI0519784A2 (pt) * 2004-12-28 2009-03-17 Asubio Pharma Co Ltd processo para a produção de compostos de aldose com carbono reduzido
IT1400964B1 (it) * 2010-06-15 2013-07-05 Dipharma Francis Srl Procedimento per la preparazione di derivati pteridinici
WO2016134257A1 (en) 2015-02-19 2016-08-25 Lixter Biotechnology, Inc. Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3468897A (en) * 1966-10-05 1969-09-23 Pierre Fournari Certain 6-amino-2-(aryl or heteroaryl)-4-chromanone-hydrazones and derivatives
JPS5829782A (ja) * 1981-08-12 1983-02-22 Nippon Zoki Pharmaceut Co Ltd 新規複素環化合物、その製法及び該化合物を含有する医薬組成物

Also Published As

Publication number Publication date
EP0238883B1 (en) 1990-05-09
US4713453A (en) 1987-12-15
CA1300138C (en) 1992-05-05
JPH0723367B2 (ja) 1995-03-15
ATE52506T1 (de) 1990-05-15
EP0238883A1 (en) 1987-09-30
ES2036183T3 (es) 1993-05-16
DE3762621D1 (de) 1990-06-13
JPS62198676A (ja) 1987-09-02
GR3000693T3 (en) 1991-09-27

Similar Documents

Publication Publication Date Title
PT81814B (pt) Processo para a preparacao de derivados de naftaleno
IE801162L (en) Pharmaceutical compositions
NO855204L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.
KR890003691A (ko) 피페리딘 유도체 및 그를 함유하는 부정맥을 위한 치료예방제
ATE35137T1 (de) Thieno(2,3-d)pyrimidin-derivate und deren salze.
EP0398720A3 (en) Piperazine derivatives
GR900300046T1 (en) Oxabicycloheptane derivatives, pharmaceutical composition and use
KR940003953A (ko) 1. 4-벤조디옥산 유도체
DE3363553D1 (en) Substituted alpha-(ethyl)-alpha-(phenyl)-(omega-(dialkylamino)-alkoxy)-benzyl alcohols, their acid addition salts and quaternary salts, process for their preparation, as well as medicines containing these compounds
CA2118425A1 (en) Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof
ES543802A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
ES8500054A1 (es) Procedimiento para preparar derivados de sulfamoilbenzofenona.
ES8802425A1 (es) Procedimiento para preparar derivados de esparteina.
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
KR870006898A (ko) 신장염 치료제
KR910011258A (ko) 녹내장의 치료방법
HUT34943A (en) Process for the production of new 1,1-diphenyl-propanol-derivatives, as well as of therapeutic preparations containing them
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.